⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

TECX News

Tectonic Therapeutic, Inc. Common Stock

Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF